A comprehensive view of Skin Disorders / Dermatology. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Beauty & Personal Care Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Mount Sinai Health System leads dermatological research for Down syndrome patients; NIH clinical trial to focus on atopic skin diseases using JAK1 inhibitors
Published: September 14, 2024 by Industry Intelligence Inc.
Eli Lilly & Co. receives FDA approval for first-line biologic treatment for moderate-to-severe eczema; new therapy targets 16.5 million American adults with condition
Published: September 14, 2024 by Industry Intelligence Inc.
FDA approves Lilly's EBGLYSS for moderate-to-severe atopic dermatitis; treatment for adults and children 12 and older targets IL-13 to reduce eczema inflammation
Published: September 13, 2024 by Eli Lilly & Co.
Sanofi SA addresses Type 2 inflammation, engages dermatologists at EADV; company focuses on disease pathology, targeted therapies for interconnected conditions
Published: September 12, 2024 by Industry Intelligence Inc.
Regeneron to present retinal disease research at EURETINA; company reports positive Phase 3 results for chronic spontaneous urticaria treatment
Published: September 12, 2024 by Industry Intelligence Inc.

Ask us about our Beauty & Personal Care market view

Trending Chart

Interactive chart with headline count